TTD | Drug: D0T9LR

Drug General Information
Drug ID	D0T9LR
Former ID	DNCL003801
Drug Name	Liprotamase
Synonyms	LY3031642
Indication	Cystic fibrosis [ICD9: 277; ICD10:E84]		Phase 3	[522063]
Company	Lilly
Target and Pathway
Target(s)	Pancreatic alpha-amylase	Target Info	Modulator	[549848]
	Triacylglycerol lipase, pancreatic	Target Info	Modulator	[549848]
	Chymotrypsin	Target Info	Modulator	[549848]
BioCyc Pathway	Triacylglycerol degradation
BioCyc Pathway	Retinol biosynthesis
KEGG Pathway	Glycerolipid metabolism
	Metabolic pathways
	Pancreatic secretion
	Fat digestion and absorption
	Vitamin digestion and absorption
Reactome	Retinoid metabolism and transport
WikiPathways	Visual phototransduction
WikiPathways	Lipid digestion, mobilization, and transport
References
Ref 522063	ClinicalTrials.gov (NCT00500084) Phase III ALTU-135 CP Safety Trial. U.S. National Institutes of Health.
Ref 549848	Clinical pipeline report, company report or official report of Anthera Pharmaceuticals.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.

Drug Information